1. Home
  2. RVMD vs CHE Comparison

RVMD vs CHE Comparison

Compare RVMD & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • CHE
  • Stock Information
  • Founded
  • RVMD 2014
  • CHE 1970
  • Country
  • RVMD United States
  • CHE United States
  • Employees
  • RVMD N/A
  • CHE N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • CHE Medical/Nursing Services
  • Sector
  • RVMD Health Care
  • CHE Health Care
  • Exchange
  • RVMD Nasdaq
  • CHE Nasdaq
  • Market Cap
  • RVMD 7.5B
  • CHE 8.0B
  • IPO Year
  • RVMD 2020
  • CHE N/A
  • Fundamental
  • Price
  • RVMD $38.27
  • CHE $451.56
  • Analyst Decision
  • RVMD Strong Buy
  • CHE Buy
  • Analyst Count
  • RVMD 13
  • CHE 4
  • Target Price
  • RVMD $69.85
  • CHE $579.75
  • AVG Volume (30 Days)
  • RVMD 1.9M
  • CHE 172.6K
  • Earning Date
  • RVMD 08-06-2025
  • CHE 07-29-2025
  • Dividend Yield
  • RVMD N/A
  • CHE 0.53%
  • EPS Growth
  • RVMD N/A
  • CHE N/A
  • EPS
  • RVMD N/A
  • CHE 19.48
  • Revenue
  • RVMD N/A
  • CHE $2,511,915,000.00
  • Revenue This Year
  • RVMD N/A
  • CHE $6.16
  • Revenue Next Year
  • RVMD $387.56
  • CHE $6.20
  • P/E Ratio
  • RVMD N/A
  • CHE $23.47
  • Revenue Growth
  • RVMD N/A
  • CHE 7.55
  • 52 Week Low
  • RVMD $29.17
  • CHE $408.42
  • 52 Week High
  • RVMD $62.40
  • CHE $623.61
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 58.95
  • CHE 49.75
  • Support Level
  • RVMD $35.62
  • CHE $443.44
  • Resistance Level
  • RVMD $37.91
  • CHE $458.66
  • Average True Range (ATR)
  • RVMD 1.29
  • CHE 8.34
  • MACD
  • RVMD 0.32
  • CHE 3.32
  • Stochastic Oscillator
  • RVMD 100.00
  • CHE 65.03

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Share on Social Networks: